Home/Filings/4/0001415889-25-007039
4//SEC Filing

Lehman David Aaron 4

Accession 0001415889-25-007039

CIK 0001127537other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 6:04 PM ET

Size

21.1 KB

Accession

0001415889-25-007039

Insider Transaction Report

Form 4
Period: 2025-03-03
Lehman David Aaron
GENERAL COUNSEL
Transactions
  • Sale

    Common Stock

    2025-03-03$7.14/sh669$4,777197,182 total
  • Sale

    Common Stock

    2025-03-03$7.14/sh4,490$32,059191,515 total
  • Sale

    Common Stock

    2025-03-03$7.97/sh13,622$108,567175,496 total
  • Sale

    Common Stock

    2025-03-03$7.14/sh1,177$8,404196,005 total
  • Sale

    Common Stock

    2025-03-03$7.14/sh2,397$17,115189,118 total
  • Award

    Common Stock

    2025-03-03+108,000283,496 total
Footnotes (7)
  • [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
  • [F2]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
  • [F3]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
  • [F4]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
  • [F5]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.88 to $8.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F7]Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025.

Issuer

Pulmonx Corp

CIK 0001127537

Entity typeother

Related Parties

1
  • filerCIK 0001354228

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:04 PM ET
Size
21.1 KB